Skip to main content
. 2020 Jul 2;10:10816. doi: 10.1038/s41598-020-67643-w

Figure 1.

Figure 1

Flowchart of the current research approach step by step to achieve the final validated gene biomarkers in terms of recurrence free survival in HER2-negative breast cancer.